Alliance Pharma (APH)
APH Share PerformanceMore
|52 week high||79.00 23/04/18|
|52 week low||47.00 22/05/17|
|52 week change||29.40 (60.00%)|
|4 week volume||23,870,016 28/03/18|
Latest News« previous» nextMore
20/04/2018 - 16:23 Interactive Investor
Given many more investors are falling into the inheritance tax trap, former AIM writer of the year Andrew Hore suggest...
19/04/2018 - 17:25 RNS
RNS Number: 5309L Alliance Pharma PLC 19 April 2018 For immediate release 19 April 2018 ALLIANCE PHARMA PLC ("Alliance" or the "Company") Annual Report and AGM Notice Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, confirms that it has today published the following documents on its website, investors.alliancepharmaceut...
19/04/2018 - 16:59 RNS
RNS Number: 5279L Alliance Pharma PLC 19 April 2018 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Alliance Pharma plc ...
19/04/2018 - 07:15 RNS
Hardman & Co Research Hardman & Co Research: Alliance Pharma (APH): Entering the US market 19-Apr-2018 / 07:15 GMT/BST Hardman & Co Research: Entering the US market Alliance Pharma (APH) is continuing with its buy-and-build strategy having evolved through 35 acquisitions over a period of 20 years into a profitable, cash-generative, specialty pharma...
17/04/2018 - 12:20 StockMarketWire
Numis today reaffirms its buy investment rating on Alliance Pharma PLC (LON:APH) and raised its price target to 88p (f...
17/04/2018 - 07:00 RNS
RNS Number: 0880L Alliance Pharma PLC 17 April 2018 For immediate release 17 April 2018 ALLIANCE PHARMA PLC ("Alliance" or the "Group") Disposal of Chinese rights to Forceval Alliance Pharma plc (AIM: APH), the specialty pharmaceutical group, announces that its wholly owned subsidiary, Alliance Pharmaceuticals Limited, has agreed to sell its 60% int...
13/04/2018 - 07:00 RNS
RNS Number: 7753K Alliance Pharma PLC 13 April 2018 For immediate release 13 April 2018 RNS REACH ALLIANCE PHARMA PLC ("Alliance" or the "Company") Alliance to present at the UK Investor Show Alliance Pharma PLC (AIM: APH) the specialty pharmaceutical company , is delighted to announce that it will be presenting at the UK Investor Show, Bri...
03/04/2018 - 16:09 RNS
RNS Number: 6905J Alliance Pharma PLC 03 April 2018 For immediate release 3 April 2018 ALLIANCE PHARMA PLC ("Alliance" or the "Company") Total Voting Rights Alliance Pharma plc (AIM: APH), the specialty pharmaceutical group, makes the following notification in accordance with the UK Financial Conduct Authority's Disclosure and Transparency R...
|Dividend yield||1.543 %|
Latest discussion posts More
“"I am following up my recent article on how shares held in ISAs can be used as part of an inheritance tax (IHT) relief portfolio by suggesting some shares that could fit the ...”▼
“Sorry to go Off Topic, but I think I have mentioned INSE here before, therefore I think it correct to point to a handy low price there at the moment. But as always DYOR. ws”▼
“Agreed, Good enough for me to get back aboard, I never felt comfortable being out, but profits must be taken sometimes. There is a miracle cure for MACD on the horizon that ...”▼
Codes & Symbols
|Symbols||APH, LSE:APH, APH.L, APH:LN, LON:APH, XLON:APH|